Related Experiment Videos
A contactless electromagnetic implantable middle ear device for sensorineural hearing loss
A J Maniglia1, W H Ko, M Rosenbaum
1Department of Otolaryngology, Head and Neck Surgery, Case Western Reserve University School of Medicine, University Hospitals of Cleveland, OH 44106.
Ear, Nose, & Throat Journal
|February 1, 1994
Summary
A novel contactless electromagnetic hearing device was successfully implanted in cats. This innovative technology shows promise for treating moderate to severe sensorineural hearing loss.
Area of Science:
- Biomedical Engineering
- Neuroscience
- Otolaryngology
Background:
- Sensorineural hearing loss affects millions globally, with limited treatment options for moderate to severe cases.
- Current treatments often involve external devices or invasive surgeries with varying success rates.
Purpose of the Study:
- To develop and test a novel contactless electromagnetic hearing device for potential treatment of sensorineural hearing loss.
- To evaluate the feasibility and efficacy of the device through acute and chronic animal experiments.
Main Methods:
- Development of precision micromechanics and electronics for a contactless electromagnetic hearing device.
- Successful implantation in cats for acute experiments, with ongoing chronic studies in cats and rabbits.
- Utilizing a highly efficient air core coil to vibrate a neodymium-iron-boron magnet attached to the incus.
- Hermetic sealing of implanted components, including hybrid circuits and solid-state electronics, via laser welding.
Main Results:
- The developed system generates sufficient force to vibrate the magnet implanted on the incus.
- Successful acute implantation in feline subjects demonstrated device feasibility.
- Ongoing chronic animal experiments are evaluating long-term component performance and biocompatibility.
Conclusions:
- The contactless electromagnetic hearing device is a viable prototype for addressing sensorineural hearing loss.
- The technology demonstrates potential for treating moderate to severe hearing impairments.
- Further chronic studies are crucial for validating long-term safety and efficacy in animal models.